Don’t Hate the Player, Hate the Game: Drug Pricing in America

Turing Pharmaceuticals recently faced intense public criticism after the company bought a 62-year-old drug and increased its price by 5,000 percent. Turing’s unusually outspoken chief executive officer, Martin Shkreli, strongly defended the decision, even going so far as to argue that the new price was still below market value. Shkreli’s brazenly unapologetic attitude — along with some eyebrow-raising behavior on social media — quickly earned him the title of “most-hated man in the United States.” A few months later, his …

The Despair That’s Killing White, Middle-Aged Americans

En español | For decades, the death rate among all groups of Americans has been steadily declining, thanks to advances in medicine and quality of life. But 15 years ago, that trend suddenly reversed for one group: white Americans ages 45 to 54. In what a new study termed “an epidemic of despair,” two Princeton economists find that suicide, alcoholism and drug abuse are driving up deaths among less-educated, middle-aged, white Americans — some of it due to job loss and financial …

It Pays to Compare Your Medicare Plan Options

It’s that time of year again: Medicare Open Enrollment. Open enrollment is the one time of year when you can re-evaluate your Medicare health and prescription drug plans and switch to ones that offer better coverage or save you money. By now you should have received your Annual Notice of Change packet of information in the mail. It’s very important to take the time to sit down and review this information to see if you want to make any changes …

Latest TPP Biologics Proposal Is a Step in the Wrong Direction

As negotiators meet on the Trans-Pacific Partnership (TPP) in Atlanta, AARP is again urging them to be mindful of the consumers who depend on prescription drugs to manage their health conditions. We continue to have serious concerns with the direction of the TPP negotiations on key issues that will have long-lasting effects on access to affordable prescriptions in the U.S. and around the world. One of AARP’s main objections centers on the intellectual property provisions in the draft TPP agreement. …

Celebrating Medicare: Strengthening the Program for the Next 50 Years

On July 30, 1965, President Lyndon B. Johnson signed the Medicare program into law. Today, we celebrate 50 years of Medicare providing affordable, guaranteed health care to millions of Americans — but we also look toward its future. We must recommit ourselves to keeping this vital lifeline strong for current and future generations. It’s easy to forget what life was like for older Americans before Medicare was enacted. Back in 1965, only about 1 in 4 Americans over age 65 …

Ambassador Froman, Don’t Let the Trans-Pacific Partnership Restrict Access to Affordable Medicine

AARP continues to voice its serious concerns about the current draft of the Trans-Pacific Partnership (TPP), a massive trade agreement that will affect millions of people here in the U.S. and abroad and could set an unfortunate precedent for future trade agreements. The draft agreement contains provisions that add to the profits of the brand-name pharmaceutical industry at the expense of patients and older Americans. In fact, some of the TPP provisions run counter to current U.S. laws that are …